Abstract
Modelling of the mechanism of covalent adduct formation by the inhibitor O-arylcarbamate URB524 in FAAH shows that only one of the two possible inhibitor binding orientations is consistent with the experimentally observed irreversible carbamoylation of the nucleophile serine: this is a potentially crucial insight for designing new covalent inhibitors of this promising drug target.
| Original language | English |
|---|---|
| Pages (from-to) | 214-216 |
| Journal | Chemical Communications |
| Volume | 2008 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2008 |
Keywords
- Fatty acids
- Inhibitors
- Chemical